GNLX (NASDAQ) director sells 10,000 shares via 10b5-1, $28,957 proceeds
Rhea-AI Filing Summary
GNLX reported a Form 144 filing disclosing a 10b5-1 sale of common stock. The filing shows Johnny Thomas sold 10,000 shares on 03/02/2026 under a 10b5-1 plan with Morgan Stanley Smith Barney LLC listed as the broker; proceeds shown were $28,957.00.
Positive
- None.
Negative
- None.
Insights
Routine insider disposition under a pre‑arranged plan; limited immediate signal.
This Form 144 records a sale of 10,000 common shares by Johnny Thomas executed pursuant to a 10b5-1 plan on 03/02/2026. The filing lists Morgan Stanley Smith Barney LLC as the executing broker.
Pre-arranged 10b5-1 sales are typically liquidity transactions; subsequent filings may show whether this reflects ongoing systematic sales. The filing itself does not state broader company operational impacts.
Key Figures
Key Terms
10b5-1 regulatory
Form 144 regulatory
AI-generated analysis. How Rhea-AI works. Not financial advice.